Session 77 - CROI 2007

Session 77 Poster Abstracts
Immunology of CD4 Cells
Monday, 1 - 4 pm
Poster Hall

389	Glucocorticoid-induced Tumor Necrosis Factor Receptor-triggering Protects HIV-specific CD4⁺ T Cells from Apoptosis Timothy Lahey*¹, S Loisel², and W Wieland-Alter¹ ¹Dartmouth Med Sch, Hanover, NH, US and ²Massachusetts Gen Hosp, Boston, US
390	HIV Infection of Primary CD4⁺ Th2 Cells, Defined by Expression of the Chemoattractant Receptor-Homologous, Induces a Th0 Phenotype B Bahbouhi, A Landay, A Tenorio, and Lena Al-Harthi* Rush Univ Med Ctr, Chicago, IL, US
391	Preservation of HIV-1-specific T-cell Responses Is Restricted to a Very Small Subset of True Non-Progressors N Qazi¹, Samantha Westrop*², F Gotch², B Gazzard¹, and N Imami² ¹Chelsea and Westminster Hosp, London, UK and ²Imperial Coll, London, UK
392	Nelfinavir Monotherapy Increases in Naïve T-cell Number in HIV-negative Healthy Young Adults Stacey Vlahakis*, E Tangalos, M McClees, M Strausbauch, P Targonsk, D McKean, P Wettstein, and A Badley Mayo Clin, Rochester, MN, US
393	Anti-viral Independent Benefit of HIV PI on T-cell Survival Stacey Vlahakis*, G Bren, S Trushin, D Schnepple, and A Badley Mayo Clin, Rochester, MN, US
394	CD4⁺CD45R0⁺CD127^-CCR5⁺ T Cells Define the Expansion of CD127^- T Cells in HIV⁺ Individuals Samandhy Cedeno*, A Llano, B Clotet, and J Este Fndn irsiCaixa, Badalona, Spain
395	Intermittent Interleukin-2 Therapy Induces the Expansion of Naïve and Central Memory CD4 T Cells and Has No Impact on HIV-specific T-cell Responses in ART-naïve HIV-infected Patients: Immunological Substudy of the ANRS 119 Interstart Trial A Venet¹, Marie-Lise Gougeon*², S Hamonic³, C Lacabaratz¹, D Séréni⁴, M Bentata⁵, I Fournier³, J P Aboulker³, J M Molina⁴, Y Lévy⁶, and ANRS 119 Interstart group ¹INSERM U802, Univ Paris XI, Kremlin Bicetre, France; ²Pasteur Inst, Paris, France; ³INSERM SC10, Villejuif, France; ⁴Hosp St Louis, Paris, France; ⁵Hosp Avicenne, Bobigny, France; and ⁶Henri Mondor Hosp, Creteil, France
396	Enhanced T-cell Apoptosis Is Not Regularly Observed in Patients with Effective ART without TCD4⁺ Gain: Its Relationship to CD86 Expression Pierre-Marie Roger*¹, V Mondain¹, I Perbost¹, J P Breittmayer², A Bernard², and P Dellamonica¹ ¹Ctr Hosp Univ Nice, France and ²INSERM 576, Ctr Hosp Univ Nice, France